본문 바로가기

Dong-A Pharmaceutical has signed an agreement to move in biopharmaceuticals
  • Date Created : 2011-09-29
  • Number of Views : 7
(110929)동아제약 바이오의약 입주협약 체결(159085)-원본
(110929)동아제약 바이오의약 입주협약 체결(159086)-원본
(110929)동아제약 바이오의약 입주협약 체결(159085)-원본
(110929)동아제약 바이오의약 입주협약 체결(159086)-원본

On Thursday, Sept. 29, 2011, IFEZ signed an agreement with Dong-A Pharmaceutical to move in biopharmaceutical. Dong-A Pharmaceutical plans to build a biosimilar manufacturing facility for antibody drugs in Songdo International City on the 145,200 square meter site.